Polyglucose Solutions in Capd

Harty J. , and Gokal R. Does CAPD provide adequate dialysis? Nephrol Dial Transplant 1995; 10: 1115–7.

Report on the management of renal failure in Europe, XXTV, 1993. Nephrol Dial Transplant 1995; 10(Suppl 5): 11–12.

Churchill D.M. , Thorpe K.E. , Nolph K.D. , Oreopoulos D.G. , Page D. , Keshaviah P.R. , for the Canada/USA Peritoneal Dialysis Study Group. CAPD patient and technique survival are worse with increased membrane permeability (Abstract). Perit Dial Int 1996; 16(Suppl 2): S21.

Heimburger O. , Waniewski J. , Werynski A. , Tranaeus A. , Lindholm B. Peritoneal transport in CAPD patients with permanent loss of ultrafiltration capacity. Kidney Int 1990; 38: 495–506.

Monquil M.C.J. , Imholz A.L.T. , Struijk D.G. , Krediet R.T. Does impaired transcellular water transport contribute to net ultrafiltration failure during CAPD? Perit Dial Int 1995; 15: 42–8.

Mistry C.D. , Gokal R. Icodextrin in peritoneal dialysis: early development and clinical use. Perit Dial Int 1994; 14(Suppl 2): S13–21.

Mistry C.D. , and Gokal R. Optimal use of glucose polymer (icodextrin) in peritoneal dialysis. Perit Dial Int 1996; 16(Suppl 1): S104–8.

Herbert S.C. , Schafer J.A. , Andreoli T.E. Principles of membrane transport. In: Brenner B.M. , Rector F.C. Jr. , eds. The Kidney (2nd ed). Philadelphia: W.B. Saunders, 1981; 116–143.

Ho-Dac-Pannekeet M.M. , Schouten N. , Langendijk M.J. Peritoneal transport characteristics with glucose polymer based dialysate. Kidney Int 1996; 50: 979–86.

Mistry C.D. , Gokal R. , Peers E.M. , and the MIDAS study group. A randomized multicenter clinical trial comparing isosmolar Icodextrin with hyperosmolar glucose solutions in CAPD. Kidney Int 1994; 46: 496–503.

Krediet R.T. , Brown C.B. , Imholz A.L.T. , Koomen G.C.M. Protein clearance and icodextrin. Perit Dial Int 1994; 14(Suppl 2): S39–44.

Peers E.M. , Scrimgeour A.C. , Haycox A.R. Cost-containment in CAPD patients with ultrafiltration failure. Clin Drug Invest 1995; 10(1): 53–8.

Wilkie M.E. , Plant M.J. , Edwards J. , Brown C.B. Icodextrin 7.5% dialysate solution (glucose polymer) in patients with ultrafiltration failure: extension of CAPD technique survival. Perit Dial Int 1997; 17(1): 84–7.

Di Paolo N. , Sacchi G. Peritoneal vascular changes in continuous ambulatory peritoneal dialysis. An in vivo model for the study of diabetic microangiopathy. Perit Dial Int 1989; 9: 41–5.

Nakayama M. , Kubo H. , Ogawa A. Immunohistochemical detection of advanced glycation end-products in the peritoneum and its possible pathophysiological role in CAPD. Kidney Int 1997; 51: 182–6.

Honda K. , Nitta K. , Horita S. , Yumura W. , Nihei H. Morphological changes in the peritoneal vasculature of patients on CAPD with ultrafiltration failure. Nephron 1996; 72: 171–6.

Ho-dac-Pannekeet M.M. , Struijk D.G. , Krediet R.T. Glucose free dialysate in patients with ultrafiltration failure: improvement of transcellular water transport. Presented to Renal Association UK, March 27–29, 1996.

Twardowski K.Z.J. , Nolph K.D. , Khanna R. Peritoneal Equilibriation Test. Perit Dial Bull 1987; 4: 139–141.

Alsop R.M. History, chemical, and pharmaceutical development of icodextrin. Peri Dial Int 1994; 14(Suppl 2): S5–12.

Lam-Po-Tang M.K.L. , Bending M.R. , Kwan J.T.C. Icodextrin hypersensitivity in a CAPD patient. Perit Dial Int 1997; 17(1): 82–4.

Krediet R.T. , Struijk D.G. , Boeschoten E.W. The time course of peritoneal transport kinetics in continuous ambulatory peritoneal patients who develop sclerosing peritonitis. Am J Kid Dis 1989; 13(4): 299–307.

Davies D. Kinetics of Icodextrm. Perit Dial Int 1994; 14(Suppl 2): S45–50.

Krediet R.T. Fluid absorption in the peritoneum — it is less simple than you thought. Nephrol Dial Transplant 1994; 9(4): 341–3.

Lamb E.J. , Worral J. , Buhler R. , Harwwod S. , Cattell W.R. , Dawnay A.B. Effects of diabetes and peritonitis on the peritoneal equilibriation test. Kidney Int 1995; 47: 1760–7.